The Prix Galien – Honoring Pharmaceutical Research and Development for 50 Years 

Katherine Vandebelt
Global Head of Clinical Innovation

Every year, the brightest minds in pharmaceuticals and clinical innovation put on their best black-tie attire for the life science industry’s biggest event – the Prix Galien. While this year may have attendees donning their ballgowns and tuxes virtually, this is still going to be one of the most important years for the Prix Galien Awards, which is celebrating its 50th anniversary, also known as the “Golden Jubilee.”

In episode nine of The Latest Dose, our host Kathy Vandebelt has the pleasure to talk more in-depth about this prestigious event and awards ceremony with Bruno Cohen, the chairman of the Galien Foundation, and Dr. Michael Rosenblatt, the co-chair of the Galien Forum, committee member of Prix Galien USA, and the chief medical officer at Flagship Pioneering. In this discussion, you’ll learn about the history of the Prix Galien Awards, why it is considered the “Nobel Prize” for pharmaceutical research and development, and find out the new additions to its program and award categories.

We are honored to be a sponsor of this impressive event and encourage everyone to register and tune in for the Galien Week of Innovation starting Oct. 26, and pit on your virtual party dress for the USA Prix Galien Awards Ceremony held on Oct. 29!


You can listen to the conversation by going to the The Latest Dose. Don’t forget to check out our other episodes, and make sure to subscribe!

Be the first to comment

Comments ( 0 )
Please enter your name.Please provide a valid email address.Please enter a comment.CAPTCHA challenge response provided was incorrect. Please try again.